Roland Valdes

3.7k total citations
77 papers, 2.8k citations indexed

About

Roland Valdes is a scholar working on Molecular Biology, Pharmacology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Roland Valdes has authored 77 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Molecular Biology, 18 papers in Pharmacology and 13 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Roland Valdes's work include Pharmacogenetics and Drug Metabolism (16 papers), Hormonal Regulation and Hypertension (11 papers) and Pharmaceutical studies and practices (7 papers). Roland Valdes is often cited by papers focused on Pharmacogenetics and Drug Metabolism (16 papers), Hormonal Regulation and Hypertension (11 papers) and Pharmaceutical studies and practices (7 papers). Roland Valdes collaborates with scholars based in United States, Canada and Germany. Roland Valdes's co-authors include Mark W. Linder, Saeed A. Jortani, Alan H.B. Wu, Fred S. Apple, Steven W. Graves, W. Brian Gibler, Robert L. Jesse, Myron M. Warshaw, Gary K. Ackers and Nancy Johnson and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Clinical Endocrinology & Metabolism and Cancer.

In The Last Decade

Roland Valdes

77 papers receiving 2.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Roland Valdes United States 29 840 822 571 358 352 77 2.8k
Osamu Okazaki Japan 37 943 1.1× 1.6k 1.9× 923 1.6× 420 1.2× 267 0.8× 159 4.4k
Arlene B. Chapman United States 27 757 0.9× 788 1.0× 352 0.6× 683 1.9× 161 0.5× 89 2.6k
Issam Zineh United States 32 867 1.0× 996 1.2× 1.1k 1.8× 483 1.3× 402 1.1× 132 4.6k
Ulrich Broeckel United States 37 1.1k 1.3× 633 0.8× 987 1.7× 295 0.8× 124 0.4× 95 3.9k
Thorir D. Bjornsson United States 28 466 0.6× 538 0.7× 666 1.2× 217 0.6× 90 0.3× 72 2.8k
Otto Bekers Netherlands 31 459 0.5× 605 0.7× 183 0.3× 229 0.6× 238 0.7× 139 3.1k
Atsushi Kurihara Japan 29 686 0.8× 1.6k 2.0× 766 1.3× 501 1.4× 193 0.5× 88 3.7k
Kazuko Nakagawa Japan 32 588 0.7× 383 0.5× 620 1.1× 339 0.9× 83 0.2× 117 2.8k
Stephan Krähenbühl Switzerland 32 988 1.2× 286 0.3× 449 0.8× 347 1.0× 71 0.2× 100 3.1k
Bart A. Ploeger Netherlands 26 630 0.8× 169 0.2× 498 0.9× 284 0.8× 137 0.4× 67 2.3k

Countries citing papers authored by Roland Valdes

Since Specialization
Citations

This map shows the geographic impact of Roland Valdes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roland Valdes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roland Valdes more than expected).

Fields of papers citing papers by Roland Valdes

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roland Valdes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roland Valdes. The network helps show where Roland Valdes may publish in the future.

Co-authorship network of co-authors of Roland Valdes

This figure shows the co-authorship network connecting the top 25 collaborators of Roland Valdes. A scholar is included among the top collaborators of Roland Valdes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roland Valdes. Roland Valdes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Egger, Michael E., et al.. (2024). Corresponding ctDNA and tumor burden dynamics in metastatic melanoma patients on systemic treatment. Translational Oncology. 42. 101883–101883. 9 indexed citations
2.
Linder, Mark W., et al.. (2021). Longitudinal Relationship between Idylla Plasma ctBRAF V600 Mutation Detection and Tumor Burden in Patients with Metastatic Melanoma. Molecular Diagnosis & Therapy. 25(3). 361–371. 4 indexed citations
3.
Dasgupta, Amitava, et al.. (2017). Model analysis of bidirectional interference in two-stage labeled-ligand immunoassays. Clinical Biochemistry. 50(18). 1188–1197. 2 indexed citations
4.
Valdes, Roland & Tyler Yin. (2016). Fundamentals of Pharmacogenetics in Personalized, Precision Medicine. Clinics in Laboratory Medicine. 36(3). 447–459. 18 indexed citations
5.
Snow, Ayelet, David Gozal, Roland Valdes, & Saeed A. Jortani. (2010). Urinary Proteins for the Diagnosis of Obstructive Sleep Apnea Syndrome. Methods in molecular biology. 641. 223–241. 13 indexed citations
6.
Linder, Mark W., et al.. (2009). Interactive Modeling for Ongoing Utility of Pharmacogenetic Diagnostic Testing: Application for Warfarin Therapy. Clinical Chemistry. 55(10). 1861–1868. 32 indexed citations
7.
Reynolds, Kristen K., et al.. (2007). Individualizing Warfarin Therapy. Personalized Medicine. 4(1). 11–31. 39 indexed citations
8.
Zhu, Yusheng, Roland Valdes, & Saeed A. Jortani. (2005). Application of Bioaffinity Mass Spectrometry for Analysis of Ligands. Therapeutic Drug Monitoring. 27(6). 694–699. 9 indexed citations
9.
Pugia, Michael J., Linda Anderson, S L Gleason, et al.. (2004). The uristatin dipstick is useful in distinguishing upper respiratory from urinary tract infections. Clinica Chimica Acta. 341(1-2). 73–81. 9 indexed citations
10.
Bukaveckas, Bonny L., Roland Valdes, & Mark W. Linder. (2004). Pharmacogenetics as related to the practice of cardiothoracic and vascular anesthesia. Journal of Cardiothoracic and Vascular Anesthesia. 18(3). 353–365. 5 indexed citations
11.
Jortani, Saeed A., et al.. (2004). Sensitive noninvasive marker for the diagnosis of probable bacterial or viral infection. Journal of Clinical Laboratory Analysis. 18(6). 289–295. 13 indexed citations
12.
Linder, Mark W., et al.. (2002). Warfarin Dose Adjustments Based on CYP2C9 Genetic Polymorphisms. Journal of Thrombosis and Thrombolysis. 14(3). 227–232. 76 indexed citations
13.
Linder, Mark W. & Roland Valdes. (2001). Genetic Mechanisms for Variability in Drug Response and Toxicity. Journal of Analytical Toxicology. 25(5). 405–413. 18 indexed citations
14.
Linder, Mark W., et al.. (2000). Detection of cocaine metabolite in serum and urine: frequency and correlation with medical diagnosis. Clinica Chimica Acta. 295(1-2). 179–185. 11 indexed citations
15.
Cao, Zhimin, et al.. (1999). Acute hypermagnesemia and respiratory arrest following infusion of MgSO4 for tocolysis. Clinica Chimica Acta. 285(1-2). 191–193. 10 indexed citations
16.
Jortani, Saeed A., et al.. (1997). Digoxin and Its Related Endogenous Factors. Critical Reviews in Clinical Laboratory Sciences. 34(3). 225–274. 38 indexed citations
17.
Jortani, Saeed A., Daniel J. Trepanier, Randall W. Yatscoff, & Roland Valdes. (1997). Convergence of Three Methods to Resolve Discrepant Immunoassay Digitoxin Results. Clinical Chemistry. 43(9). 1805–1808. 10 indexed citations
18.
Valdes, Roland, James M. Hagberg, Thomas E. Vaughan, et al.. (1988). Endogenous digoxin-like immunoreactivity in blood is increased during prolonged strenuous exercise. Life Sciences. 42(1). 103–110. 21 indexed citations
19.
Valdes, Roland, et al.. (1983). Endogenous substance in newborn infants causingfalse positive digoxin measurements. The Journal of Pediatrics. 102(6). 947–950. 112 indexed citations
20.
Valdes, Roland & Gary K. Ackers. (1974). Calorimetric determination of polymerization enthalpy for bacterial flagellin (Salmonella). Biochemical and Biophysical Research Communications. 60(4). 1403–1409. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Osamu Okazaki Breakdown of academic impact, for papers by Arlene B. Chapman Breakdown of academic impact, for papers by Issam Zineh Breakdown of academic impact, for papers by Ulrich Broeckel Breakdown of academic impact, for papers by Thorir D. Bjornsson Breakdown of academic impact, for papers by Otto Bekers Breakdown of academic impact, for papers by Atsushi Kurihara Breakdown of academic impact, for papers by Kazuko Nakagawa Breakdown of academic impact, for papers by Stephan Krähenbühl Breakdown of academic impact, for papers by Bart A. Ploeger
Rankless by CCL
2026